LifePoint Hospitals, Inc.
 (LPNT)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Fri, Jan. 22, 8:38 AM
    • Zafgen's (NASDAQ:ZFGN) recent bullish action gets some attention: FBR & Co. upgrades to Outperform from Market Perform. Price target raised to $20 (120% upside) from $9; RBC Capital upgrades to Outperform from Sector Perform. Price target raised to $21 (131% upside).
    • Anthem (NYSE:ANTM) upgraded to Buy from Neutral by Goldman Sachs. Price target raised to 168 (21% upside) from $160.
    • Kite Pharma (NASDAQ:KITE) upgraded to Outperform from Market Perform by FBR & Co. Price target raised to $75 (47% upside) from $72.
    • AstraZeneca (NYSE:AZN) upgraded to Equal Weight from Underweight by Barclays. Price target raised to ₤50 from ₤44.
    • LifePoint Health (NASDAQ:LPNT) downgraded to Neutral from Buy by Goldman Sachs. Price target lowered to $78 (17% upside) from $81.
    | Fri, Jan. 22, 8:38 AM
  • Dec. 18, 2015, 12:18 PM
    • Biogen (BIIB +0.2%) initiated with Overweight rating and $344 (16% upside) price target by Atlantic Equities.
    • CVS Health (CVS -0.1%) initiated with Overweight rating and $110 (16% upside) price target by Barclays.
    • Clovis Oncology (CLVS +0.9%) initiated with Buy rating and $50 (48% upside) price target by Janney.
    • Relypsa (RLYP +2.6%) initiated with Buy rating and $63 (123% upside) price target by H.C. Wainwright.
    • HCA Holdings (HCA -0.2%) initiated with Outperform rating and $75 (16% upside) price target; LifePoint Health (LPNT +0.4%) with an Outperform rating and $79 (13% upside) price target; Tenet Healthcare (THC +1.2%) with a Neutral rating and $33 (18% upside) price target and Universal Health Services (UHS +0.4%) with a Neutral rating and $129 (11% upside) price target by Credit Suisse.
    • Amgen (AMGN -0.1%) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target raised to $193 (20% upside) from $160.
    • Valeant Pharmaceuticals (VRX -1.8%) downgraded to Neutral from Buy by Mizuho Securities. Price target raised to $130 (19% upside) from $111.
    | Dec. 18, 2015, 12:18 PM
  • Oct. 30, 2015, 10:52 AM
    • LifePoint Hospitals (LPNT +1.3%) Q3 results: Revenues: $1,309.5M (+12.3%); Salaries and Benefits: $626.2M (+12.1%); Supplies: $205.7M (+14.0%); Other Operating Expense: $313.2M (+9.7%); Net Income: $43.6M (+58.5%); EPS: $0.94 (+59.3%); Quick Assets: $313.2M (+63.6%).
    • No guidance given.
    | Oct. 30, 2015, 10:52 AM
  • Oct. 30, 2015, 7:07 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q3 EPS of $0.94 may not be comparable to consensus of $0.90.
    • Revenue of $1.31B (+12.0% Y/Y) beats by $10M.
    | Oct. 30, 2015, 7:07 AM
  • Oct. 29, 2015, 5:30 PM
    | Oct. 29, 2015, 5:30 PM | 19 Comments
  • Jul. 31, 2015, 10:09 AM
    • LifePoint Hospitals (LPNT -3.9%) Q2 results: Revenues: $1,270.4M (+21.3%); Salaries and benefits: $606.8M (+24.2%); Supplies: $194.1M (+19.4%); Other operating expenses: $308.7M (+19.5%); Net Income: $46.4M (+18.7%); EPS: $1.00 (+19.0%); Quick Assets: $422.8M (+120.8%).
    • 2015 Guidance: Net Revenue: $5.15B - 5.25B; Adjusted EBITDA: $695M - 720M; Adjusted EPS: $3.75 - 4.06.
    | Jul. 31, 2015, 10:09 AM
  • Jul. 31, 2015, 7:03 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q2 EPS of $1.00 beats by $0.01.
    • Revenue of $1.27B (+21.0% Y/Y) beats by $30M.
    | Jul. 31, 2015, 7:03 AM
  • Jul. 30, 2015, 5:30 PM
    | Jul. 30, 2015, 5:30 PM | 4 Comments
  • Jun. 29, 2015, 3:30 PM
    • Becton, Dickinson (BDX +0.3%) upgraded to Buy from undefined with a $167 (18% upside) price target by UBS.
    • Community Health Systems (CYH -0.9%) upgraded to Buy from Neutral with an $83.90 (33% upside) price target by Mizuho Securities.
    • LifePoint Health (LPNT +2.8%) upgraded to Buy from Neutral with a $95.71 (11% upside) price target by Mizuho Securities.
    • UnitedHealth Group (UNH -1.3%) upgraded to Buy from Neutral with a $126 (3% upside) price target by Sterne Agee CRT.
    • Tenet Healthcare (THC -1.5%) upgraded to Outperform from Market Perform with a $64 (12% upside) price target by Wells Fargo.
    • Cepheid (CPHD -1.7%) raised to Buy from Hold with a $75 (25% upside) price target by Craig-Hallum.
    • Merge Healthcare (MRGE -0.1%) upgraded to Buy from Hold with a $5.75 (17% upside) price target by Topeka Capital.
    • Alere (ALR -0.2%) upgraded to Buy from Neutral with a $60 (15% upside) price target by Goldman Sachs.
    • Smith & Nephew (SNN -2.1%) upgraded to Buy from Neutral with a 1275p (16% upside) price target by UBS.
    • Aerie Pharmaceuticals (AERI -4.3%) upgraded to Buy from Hold with a $40 (135% upside) price target by Canaccord Genuity.
    | Jun. 29, 2015, 3:30 PM
  • Jun. 26, 2015, 5:37 PM
    | Jun. 26, 2015, 5:37 PM | 16 Comments
  • Jun. 12, 2015, 12:17 PM
    • AMAG Pharmaceuticals (AMAG -1.5%) initiated with Hold rating and $75 (10% upside) price target by Deutsche Bank.
    • Supernus Pharmaceuticals (SUPN +9.5%) initiated with Buy rating and $30 (70% upside) price target by SunTrust Robinson Humphrey.
    • Plasmatech Biopharmaceuticals (PTBI -2.7%) initiated with Buy rating and $16 (118% upside) price target by Roth Capital.
    • Horizon Pharma (HZNP -0.4%) initiated with Overweight rating and $38 (19% upside) price target by Morgan Stanley.
    • Depomed (DEPO -2.1%) initiated with Equal Weight rating and $23 (10% upside) price target by Morgan Stanley.
    • Community Health Systems (CYH +0.5%) initiated with Outperform rating and $65 (19% upside) price target by Wedbush.
    • HCA Holdings (HCA -0.1%) initiated with Outperform rating and $93 (11% upside) price target by Wedbush.
    • LifePoint Health (LPNT -0.2%) initiated with Neutral rating and $80 (5% upside) price target by Wedbush.
    • HealthSouth (HLS) initiated with Neutral rating and $46 (3% downside risk) price target by Wedbush.
    • Adeptus Health (ADPT -0.4%) initiated with Overweight rating and $106 (26% upside) price target by KeyBanc.
    • Universal Health Services (UHS -0.1%) initiated with Neutral rating and $141 (7% upside) price target by Janney Capital.
    • Owens & Minor (OMI -0.2%) initiated with Sector Perform rating and $35 (3% upside) price target by RBC Capital.
    • Henry Schein (HSIC -0.6%) initiated with Outperform rating and $165 (16% upside) price target by RBC Capital.
    | Jun. 12, 2015, 12:17 PM | 5 Comments
  • Jun. 9, 2015, 10:55 AM
    • CVS Health (CVS -0.1%) initiated with Outperform rating and $115 (16% upside) price target by Macquarie.
    • Galapagos (GLPG -3%) initiated with Overweight rating and $73 (36% upside) price target by Morgan Stanley.
    • LifePoint Health (LPNT) initiated with Conviction Buy rating and $92 (25% upside) price target by Goldman Sachs.
    • BioMarin Pharmaceutical (BMRN -2.2%) initiated with Overweight rating and $150 (24% upside) price target by Barclays.
    • Universal Health Services (UHS +0.2%) initiated with Neutral rating and $140 (10% upside) price target by Goldman Sachs.
    • Amsurg (AMSG -0.5%) initiated with Buy rating and $81 (17% upside) price target by Goldman Sachs.
    • Momenta Pharmaceuticals (MNTA -2.6%) initiated with Buy rating and $26 (18% upside) price target by Stifel Nicolaus.
    • Actavis (ACT -0.6%) initiated with Outperform rating and $344 (16% upside) price target by Raymond James.
    | Jun. 9, 2015, 10:55 AM
  • May 11, 2015, 7:56 AM
    • In order to reflect its evolution from an operator of community hospitals to an broad healthcare services organization, LifePoint Hospitals (NASDAQ:LPNT) changes its name to LifePoint Health.
    • In addition to hospitals, the firm's portfolio of services now includes physician practices, post-acute services, outpatient services and wellness/prevention programs. It operates facilities in more than 60 communities in 20 states, including more than 60 hospitals, 1,100 physician practices, 40 post-acute service providers and 30 outpatient centers.
    | May 11, 2015, 7:56 AM
  • May 1, 2015, 7:57 AM
    • LifePoint Hospitals (LPNT -1.5%) Q1 results: Revenues: $1,263.7M (+25.5%); Salaries and benefits: $611.2M (+28.7%); Supplies: $196.8M (+25.4%); Other operating expenses: $293.6M (+20.6%); Net Income: $38.9M (+4.9%); EPS: $0.84 (+7.7%); Quick Assets: $281.9M (+47.2%); CF Ops: $179.6M (+65.4%).
    • No guidance given.
    | May 1, 2015, 7:57 AM
  • May 1, 2015, 7:07 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q1 EPS of $0.84 may not be comparable to consensus of $0.99.
    • Revenue of $1.26B (+24.8% Y/Y) beats by $20M.
    | May 1, 2015, 7:07 AM
  • Apr. 30, 2015, 5:30 PM
    | Apr. 30, 2015, 5:30 PM | 5 Comments
Company Description
LifePoint Health Inc is a healthcare company dedicated to Making Communities Healthier. The Company through its subsidiaries provides inpatient, outpatient and post-acute services close to home.
Sector: Healthcare
Industry: Hospitals
Country: United States